The assembly of individual epithelial or endothelial cells into a tight cellular sheet requires stringent control of cell packing and organization. These processes are dependent on the establishment and further integration of cellular junctions, the cytoskeleton and the formation of apical-basal polarity. However, little is known how these subcellular events are coordinated. The (Angiomotin) Amot protein family consists of scaffold proteins that interact with junctional cadherins, polarity proteins and the cytoskeleton. In this report, we have studied how these protein complexes integrate to control cellular shapes consistent with organ function. Using gene-inactivating studies in zebrafish and cell culture systems in vitro, we show that Par3 to be essential for localization of AmotL2 to cellular junctions to associate with VE/E-cadherin and subsequently the organization of radial actin filaments. Our data provide mechanistic insight in how critical processes such as aortic lumen expansion as well as epithelial packing into hexagonal shapes are controlled.
The establishment of different type of junctions and their components from which they consist were studied extensively. On the contrary, how the junction proteins come to localize to the correct membrane domain, and further how signals from junctional and polarity components intersect and transduce to finally merge into intra as well as supracellular signaling, is not yet clear.
We provide evidence for AmotL2 and Par3 being part of the same pathway regulating the actin cytoskeleton in both endothelia during aortic lumen formation and in skin epithelium. By doing so, we show the importance of linkage and coordination of polarity and cell-cell adhesion proteins for proper organization of trans-cellular actin filaments. Further, precise assembly of adherens junction associated actin filaments is required for hexagonal packing essential for the development and maintenance of a stable cellular sheet.
Results
Par3 is required for dorsal aorta formation in zebrafish. Similar to AmotL2, Par3 has been reported to be important for aortic lumen formation, as expression of Par3 was shown to rescue aortic defects caused by β1-integrin deletion in mice 15, 16 . A zebrafish orthologue to Par3 has been reported, which present high homology to mammalian Par3 regarding amino acid identity and organization of functional domains 17 . To analyze the role of Par3 during vascular development in zebrafish, we used anti-sense morpholino oligos to functionally inactivate Par3 17 . As higher doses of par3 morpholinos were previously shown to cause severe brain and eye defects, the concentrations were reduced to allow detection of potential vascular defects 17 . At 48hpf the par3 morphants presented with pericardial and brain edema and further lacked circulation, the latter similar to what was observed in the amotL2a/b MO (Fig. 1a) . Accordingly, using the double transgenic Tg(gata1:dsRed) sd2 ); Tg(kdrl:EGFP) s843 embryos, we could detect pericardial accumulation of the dsRed positive erythrocytes (Fig. 1a) . In contrast, the control embryos had established circulation and dsRed positive erythrocytes were found circulating within the EGFP expressing vasculature (Fig. 1a ). To study the circulatory phenotype more closely, 48hpf Tg(fli1a:EGFP) y1 control and par3 morphants embryos were analyzed by vibratome sectioning. In accordance with previously published findings in mice, a lumen defect was observed in the dorsal aorta, while the vein was lumenized ( Fig. 1b,) 16 . The dorsal aorta was narrow, with prominent constrictions (Fig. 1c ), and interestingly the phenotype phenocopied our previously observed findings in the amotL2 MO zebrafish embryos ( Fig. 1b ,c,) 15 . The efficiency of the par3 morpholinos to reduce Par3 protein levels was confirmed by western blot ( Fig. 1d and Supplementary Fig. 3a ). The same circulatory phenotype could be obtained using two different par3 morpholinos and the phenotype could further be rescued by co-injecting the morpholinos with a human PAR3 mRNA. This argues for specificity of the detected phenotype ( Fig. 1e, Supplementary Fig. 3a-c) . The association between the two proteins was further strengthened by the observation that rescue of the AmotL2 MO circulatory phenotype was dependent on the PDZ-binding domain, previously shown to interact with Par3 ( Fig. 1f,) 12 .
Par3 controls actin filament organization during development of zebrafish skin. In endothelial cells, AmotL2 is required for connection of radial actin filaments to VE-cadherin 15 . Amotl2a is also expressed in the zebrafish skin cells of the developing epidermis, where it is localized to cell-cell junctions, as well as actin filaments ( Fig. 2a ). We have recently shown that, in analogy with endothelial cells, AmotL2 associates to E-cadherin in zebrafish, mouse and human cells and is required for epithelial geometry and blastocyst hatching 14 . In zebrafish skin, depletion of AmotL2 resulted in loss of cytoplasmic filaments and change in cell area and epithelial packing as previously published by Hildebrand et al. (Fig. 2b) 14 . We went on to investigate whether depletion of Par3 in the zebrafish skin would affect AmotL2 junctional organization and actin filament structures. The phenotype of par3 MO did partially overlap with that of amotl2 MO in that cytoplasmic actin filaments were lost and cell area was significantly increased ( Fig. 2a and d ). Furthermore a similar defect in geometrical cell packing was observed in the par3 and amotl2 morphants ( Fig. 2e ). Analysis of AmotL2a localization showed a significant decrease of AmotL2 staining in cellular junctions ( Fig. 2a ,c). In comparison to amotl2 morphants, the par3 MO phenotype was more severe as junctions appeared less intact ( Fig. 2a ). Both the increased cell area and the altered polygonal distribution could be rescued by co-injection with a human PAR3 mRNA ( Fig. 2a,e ). In accordance with the results from the Par3 depletion in vasculature, the par3 MO skin phenotype strongly mimics the phenotype observed in the amotL2 morphants ( Fig. 2,) 14 .
AmotL2 and Par3 form a protein complex controlling actin filament induction from adherens junctions. The expression pattern of AmotL2 and Par3 was compared using immunofluorescence staining. As expected, expression of both proteins could be detected at the cell-cell junctions in Bovine Capillary Endothelial (BCE) cells ( Fig. 3a ). Co-immunoprecipitation analysis showed AmotL2 and Par3 to be part of the same protein complex (Fig. 3b ). In addition, the role of Par3 in controlling actin cytoskeleton architecture could be confirmed by small interfering RNA (siRNA) analysis in Mile Sven-1 mouse pancreatic islet endothelial cells (MS-1) in-vitro. Here, depletion of Par3 resulted in loss of radial actin filaments but did not affect steady-state levels of AmotL2 ( Fig. 3c,d ).
Par3 is essential for junctional localization of AmotL2. To further analyze the functions of the AmotL2-Par3 interaction, we used siRNA to target the two proteins individually in MS-1 cells. Interestingly, the junctional localization of AmotL2 was lost in Par3 siRNA-depleted cells as AmotL2 localization was not overlapping with β-catenin at cell-cell junctions (Fig. 4a,c) . In contrast, silencing AmotL2 did not affect spatial distribution of Par3, which was localized to cell-cell junctions both in control and AmotL2 siRNA treated cells ( Fig. 4b,d ). No effect on total protein levels of par3 was observed in MS-1 cells, arguing for an effect mainly on the localization ( Supplementary Fig. 1a ). These findings suggest that Par3 plays an important role in targeting AmotL2 to the cellular junction, whereas AmotL2 is dispensable for Par3 localization. The same result could be obtained using HaCaT (human keratinocytes) cells, implying that this is a conserved mechanism among tissues par3 MO (bottom) injected embryos at 48hpf. The par3 morphants exhibited pericardial (arrowhead) and brain (arrow) edema. In addition, they lacked circulation, and no erythrocytes could be observed in the trunk vasculature (arrowhead). Scale bar, 100 μm. (b) Transverse sections of 48hpf Tg(fli1a:EGFP) y1 control (top row) and par3 (mid row) morphants. Sections were stained with phalloidin for F-actin (red) and TO-PRO-3 iodide to visualize nuclei (blue). In control embryos patent lumens could be observed in both the dorsal aorta (red asterisk) and cardinal vein (blue asterisk). The par3 morphants showed narrow aortic lumens with present constrictions (arrowhead), while the vein was lumenized (white asterisk). As a comparison sections of amotL2a/b embryos were also included (bottom row). Note the similarity of the aortic phenotype. Scale bar, 10 μm. (c) Sagittal view of the DA (red bracket/ arrowhead) and PCV (blue bracket/ arrowhead) in control, par3 and amotL2 morphants. Both amotL2 and par3 morphants show DA constrictions (arrowheads) and reduced DA diameter. Scale bar, 50 μm. ( Supplementary Fig. 1b ). Further, the results were strengthened by analysis of Par3 localization in zebrafish skin. By injecting mRNA encoding human Par3-GFP 18 , alone or in combination with AmotL2 morpholinos, we were able to study the effect of AmotL2 on Par3 localization. Par3-GFP could be detected in zebrafish skin cells where it was localized to cell-cell junctions independent of AmotL2 levels ( Supplementary Fig. 2a ). We conclude that Par3 is required for AmotL2 junctional localization and the formation of radial actin filaments.
Par3 is essential for AmotL2/E-cadherin interaction. We have previously shown that AmotL2 was important for VE/E-cadherin dependent actomyosin contractility 14, 15 . We continued to analyze the role of Par3 in the interaction of AmotL2 with the E-cadherin adherens junction protein complex. Interestingly, silencing of Par3 using siRNAs in HaCaT cells totally abrogated the association of AmotL2 to E-cadherin, MAGI-1 and β-actin ( Fig. 4e) as evaluated by co-IP. In conclusion, these findings suggest the AmotL2/ E-cadherin interaction to be mediated at the cell membrane. The components of the protein complex would be individually targeted to the same membrane domain, where they later associate to allow induction of actin filaments and connection of neighbouring cells (Fig. 5) . 
Discussion
Despite extensive studies regarding the composition and organization of adhesive contacts, it has not yet been revealed how the junctional proteins are targeted to the correct membrane domain. In this report, present data connecting Par3 to the junctional localization of AmotL2 and subsequent organization of actin filaments. By bridging adherens junctions and its associated actin filaments to polarity signaling, we propose Par3 and AmotL2 to form a molecular complex, translating polarity cues into co-ordinated actomyosin organization.
Recently, both Par3 and AmotL2 have been shown to interact with VE/E-cadherin at the adherens junction 10, 14, 15 . In this study, we demonstrate Par3 and AmotL2 to be part of a common adherens junction associated signaling complex. Silencing of Par3 was shown to cause disorganization of radial actin cytoskeleton as previously observed in AmotL2 knockdown studies. In more detail, the cells were lacking transcellular actin filaments, while the cortical actin appeared intact. As a consequence, the cells present with an altered morphology and the hexagonal patterning was lost. However, since VE/E-cadherin is associated to both transcellular actin filaments and cortical membrane associated actin, we cannot exclude loss of function of the latter as a contributing factor to the altered cell shape observed in AmotL2 and Par3 KD 3 .
Interestingly, when silencing Par3, we observed an apparent re-localization of AmotL2 from cell-cell junctions to cytoplasmic vesicles. On the contrary, we were not able to observe any difference in total AmotL2 protein levels, arguing against a control mechanism at the transcriptional level. Silencing of Par3 did not seemingly affect junctional localization of VE/E-cadherin or the associated catenins. Instead we report, Par3 is essential for proper localization of AmotL2 to the correct membrane domain. This is in line with previous findings presenting a difference in E-cadherin stability, but not localization, in the absence of Par3 11 .
Traditionally Par3 has been associated to Par6 and aPKC, playing a key role during epithelial/endothelial cell apical-basal polarization. As we have been unable to show any effect of AmotL2-silencing on apical-basal polarity, we propose Par3 to be part of two functionally distinct protein complexes. Accordingly, we here describe the association of Par3 to AmotL2 and VE-cadherin, forming a novel adherens junction associated protein complex controlling the actin cytoskeleton. This is in agreement with findings by Iden et al. p 10 , providing evidence for a distinct subset of VE-cadherin interacting with PAR proteins in endothelial cells.
As Par3 has been suggested to be associated to the Extracellular Matrix (ECM) through an interaction with β1-integrin 16 , it is tempting to speculate, that this interaction would further localize AmotL2 to the adherens junctions. Potentially, mechanosensing through β1-integrins at the focal adhesions could, through Par3 signaling, induce re-localization of AmotL2 from cytoplasmic vesicles to the adherens junctions. Once in its correct location, the AmotL2/cadherin/catenin protein complex would allow induction of actin filament formation from the adherens junction, and further reinforcement of the junction to better withstand external force.
Taken together, we have revealed a role for the polarity protein Par3 in targeting AmotL2 to cell-cell junctions. Once at the site, AmotL2 and Par3 interact with VE/E-cadherin and associated catenins, to induce transcellular actin filaments anchoring neighbouring cells, and allowing proper cell sheet formation. We hypothesize the AmotL2-Par3 junctional recruitment to be activated through β1-integrin signaling at the focal adhesions. Converting polarity signals into actin cytoskeletal modifications, we propose this signaling pathway to be part of a machinery enabling sensing of the micro-environment.
Since the actin fibers are not limited to one cell length, but instead span through several cells, the force initially sensed at the basal cell-ECM interface can be transmitted in between cells, coordinating the neighboring cells into a synchronized tissue. Hence, mislocalization of junctional components might have big implication both on cell and tissue level. Accordingly, strengthening of junctions and connection in between cells is commonly lost during tumor progression. Hence, this study can be of importance not only for understanding of developmental processes but also for advances within tumor biology.
Materials and Methods
Zebrafish strains. Zebrafish were raised and housed under standard conditions and in agreement with the regulations set out by the Swedish Board of Agriculture for the use of laboratory animals in scientific research. The following previously described transgenic lines were used in this study: Tg(kdrl:EGFP) s843 19 Tg(gata1:dsRed) sd2 20 Tg(fli1a:EGFP) y1 21 All experiments were performed in accordance with relevant guidelines and regulations. All experimental protocols were approved by the regional ethics board (Jordbruksverket.se).
DNA, RNA and morpholino injections into zebrafish embryos. Morpholinos were purchased from
Gene Tools (Philomath, Oregon, USA). The following morpholinos were used in this study: amotl2a MO 5′-CTGATGATTCCTCTGCCGTTCTCAT-3′ 14, 15 amotl2b MO 5′-TGAGTATTTATGATCTGAGCTGAAC-3′ 14, 15 par3 MO1 5′-TCAAAGGCTCCCGTGCTCTGGTGTC-3′ 17 , par3 MO3 5′-TCCCGTGCTCTGGTGTCAAGATCAT-3′ 17 control 5′-CCTCTTACCTCAGTTACAATTTATA-3′
The amotl2a morpholino was injected at 1.5 ng per embryo and the amotl2b morpholino was injected at 3 ng per embryo. Morpholino-injected zebrafish embryos were maintained at 28 °C in standard E3 water supplemented with 0.003% phenyl-2-thiourea.
mRNA encoding wildtype or mutant human AMOTL2 or PAR3 were synthesized using the SP6 Message Machine kit (Ambion, Austin, TX, USA), and 50 pg per embryos were co-injected with morpholinos for rescue experiments. Embryos were fixed in 4% PFA at 28hpf for cell area analysis and at 34 hpf quantification of cell corners. For visualization of Par3-GFP 18 , living embryos were sedated with tricaine and mounted into 1% low-melt agarose on a coverslip. All experiments were performed in accordance with relevant guidelines and regulations. All experimental protocols were approved by the regional ethics board (Jordbruksverket.se).
Immunofluorescence staining of zebrafish embryos. PFA fixed zebrafish embryos were washed in PBS-T, and further permeabilized in PBS-T containing 0.5% TritonX-100 for 30 minutes at room temperature (RT). Blocking was performed for two hours at RT, in a solution comprised of 0.1% TritonX-100, 5% Normal Goat Serum (NGS) and 1% BSA, all diluted in PBS-T. Antibodies were also diluted in this solution and antibody incubations were performed over night in +4 °C. After antibody incubations embryos were washed in PBS-T for 2 h (after primary antibody) and 4 h (after secondary antibody). For vibratome sections fixed embryos were mounted in 4% low-melt agarose and sectioned with a Leica Vibratome at a thickness of 200μm. Sections were stained with TexasRed-X Phalloidin (1:200, #T7471, Invitrogen) for visualizing F-actin and TO-PRO-3 iodide (1:1000, #T3605, Invitrogen) for labeling of the nuclei. Paralogue-specific epitopes were chosen for the production of anti-amotL2a antibodies. Affinity-purified rabbit polyclonal antibodies against the zebrafish amotL2a protein were made using the antibody production services of Innovagen (Lund, Sweden). For amotL2a, antibodies were made against the C-terminal epitope:
NH2-CQKAPSAVDLFKGVDDVSAE-COOH (1:200) . All experiments were performed in accordance with relevant guidelines and regulations. All experimental protocols were approved by the regional ethics board (Jordbruksverket.se).
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Immunofluorescence staining of cells. Cells were washed in 1xPBS and fixed in 4% PFA for 10 minutes at room temperature (RT). After washing, permeablization was performed with TritonX-100 for 1 minute in RT. The cells were washed again and blocked for 1 h in 5% horse serum in PBS. Antibodies were diluted in the blocking solution, and all incubations were performed at RT. Incubations were 1-2 hours for primary antibodies and 45 minutes for secondary antibodies. The following antibodies and dyes were used:
anti-Par3 (1:100, rabbit polyclonal, #07-330, Millipore), anti-β-catenin (1:100, mouse monoclonal, #610154, BD Transduction Laboratories), TO-PRO-3 Iodide (1:1000, #T3605, Invitrogen), Phalloidin-TexasRed (1:200, #T7471, Invitrogen), AlexaFlour 488/568 secondary antibodies (1:1000, Invitrogen). AmotL2 was detected with a rabbit affinity-purified antibody against the C-terminal motif of human amotL2; NH2-CLDSVATSRVQDLSDMVEILI-COOH (1:50). Images were taken on a Zeiss LSM700 confocal microscope. Image J was used to measure the fluorescence intensities and to process the images acquired.
Co-Localization Analysis. Co-localization of (AmotL2/Par3) with β-Catenin was calculated using the Coloc module of Imaris (Bitplane AG). The images (Z-Stacks) obtained from the confocal (Zeiss LSM700) microscope were loaded in Imaris and the automatic threshold function in the software was chosed for the green and red channels. Then the voxel intensities of the two channels green (AmotL2/Par3) and red (β-Catenin) in the junctions were used to calculate the Pearson Correlation Coefficient. siRNA transfections. Cells were seeded on glass slides (BD Falcon Cultureslides BD Biosciences) coated with 1% BD Matrigel Basement Membrane Matrix (BD Biosciences) in growth medium without antibiotics. Next day the growth medium was exchanged for OPTI-MEM I Reduced Serum Media (Invitrogen) and siRNA transfections were performed using Oligofectamine Transfection Reagent (Invitrogen) according to the manufacturer's protocol. Four hours after transfection serum was added to a final concentration of 20%. Cells were allowed to grow for 72 h prior to the evaluation by immunofluorescence staining or western blot.
The following siRNA's were used: siGENOME siRNAs against mouse AmotL2 (0.32 μM, M-062016-01, Dharmacon/Thermo Scientific). siGENOME siRNAs against mouse Par3 (0.64 μM, M-040036-01, Dharmacon/Thermo Scientific). non-targeting siRNA Pool #2 (0.32/ 0.64 μM, D 001206-14, Dharmacon/Thermo Scientific). siGENOME siRNAs against human AMOTL2 (0.32 μM, M-013232-00, Dharmacon/Thermo Scientific). ON-TARGETplus siRNAs against human PAR3 (0.32 μM, L-015602-00, Dharmacon/Thermo Scientific).
Immunoprecipitation and western blotting. For immunoprecipitation analysis cell lysates were prepared using a buffer containing 50 mM Tris-HCL pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% Nonident P40 and 1 x protease inhibitor (Roche). Lysates were incubated with a rabbit affinity-purified antibody against the C terminal motif of human amotL2; NH2-CLDSVATSRVQDLSDMVEILI-COOH or with rabbit immunoglobulins as a control. Antibody incubations were performed for 2 hours under rotation at 4°C. Protein G Sepharose beads (GE Healthcare) were added for additional 2 hours. Beads were washed 4 times with lysis buffer and heated for 10 min at 95 °C in 2 x LDS sample buffer (Novex) containing 10% sample reducing agent (Novex). Immunocomplexes bound to the beads were separated by SDS-PAGE and AmotL2 binding proteins were detected by western blot. Fractions of whole cell lysates were western blotted for evaluation of IP protein input level.
The following antibodies were used: anti-Par3 (rabbit polyclonal. #07-330, millipore), anti-Par6 (rabbit polyclonal, #ab45394-100, abcam), anti-aPKC (anti-rabbit, #sc-216, santa cruz), anti-E-cadherin (1:500, mouse monoclonal, #610183, BD Transduction Laboratories), anti-β-catenin (1:500, #610154, 14/beta-catenin, BD Transduction Laboratories), anti-α-catenin (1:500, #610193, 5/alpha-catenin, BD Transduction Laboratories), anti-MAGI1 (1:500, #WH0009223M3, 7B4, Sigma), anti-β-actin (1:20000, #ab3280, ALTN05CC4, Abcam), Tubulin (Sigma, T5168). AmotL2 was detected with a rabbit affinity-purified antibody against the C-terminal motif of human amotL2; NH2-CLDSVATSRVQDLSDMVEILI-COOH (1:500).
